These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 20698202

  • 1. Effective treatment of advanced cholangiocarcinoma by hepatic arterial infusion chemotherapy combination with sorafenib: one case report from China.
    Qun W, Tao Y.
    Hepatogastroenterology; 2010; 57(99-100):426-9. PubMed ID: 20698202
    [Abstract] [Full Text] [Related]

  • 2. [A case report--intrahepatic arterial infusion with CDDP and S-1 administration can elicit long-term survival for the patient with recurrenced intrahepatic cholangiocarcinoma after resection].
    Tanida T, Tanemura M, Kobayashi S, Wada H, Marubashi S, Eguchi H, Takeda Y, Umeshita H, Mori M, Doki Y, Nagano H.
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2729-31. PubMed ID: 21224694
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hepatic arterial infusion of mitomycin C with degradable starch microspheres for unresectable intrahepatic cholangiocarcinoma.
    Shitara K, Ikami I, Munakata M, Muto O, Sakata Y.
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):241-6. PubMed ID: 18222071
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [A case of successful management of advanced cholangiocellular carcinoma by repeated hepatic resection].
    Nakano H, Sasaki Y, Imaoka S, Furukawa H, Ishikawa O, Kabuto T, Kameyama M, Hiratsuka M, Ohigashi H, Nakamori S, Yasuda T, Iwanaga T.
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1603-6. PubMed ID: 8854817
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Successful treatment for advanced cholangiocellular carcinoma with intrahepatic metastasis and/or portal vein tumor thrombi by intraarterial chemotherapy combined with 5-fluorouracil, adriamycin and cisplatin (FAP)--two cases report].
    Wada H, Nagano H, Dono K, Kondo M, Yamamoto T, Ota H, Nakamura M, Yoshioka S, Damdinsuren B, Yubo Y, Marubashi S, Miyamoto A, Umeshita K, Nakamori S, Sakon M, Monden M.
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1711-3. PubMed ID: 15553691
    [Abstract] [Full Text] [Related]

  • 10. Positioning of a molecular-targeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in Japan.
    Kudo M, Ueshima K.
    Oncology; 2010 Jul; 78 Suppl 1():154-66. PubMed ID: 20616599
    [Abstract] [Full Text] [Related]

  • 11. Sorafenib alone or as combination therapy for growth control of cholangiocarcinoma.
    Huether A, Höpfner M, Baradari V, Schuppan D, Scherübl H.
    Biochem Pharmacol; 2007 May 01; 73(9):1308-17. PubMed ID: 17266941
    [Abstract] [Full Text] [Related]

  • 12. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.
    Liu L, Cao Y, Chen C, Zhang X, McNabola A, Wilkie D, Wilhelm S, Lynch M, Carter C.
    Cancer Res; 2006 Dec 15; 66(24):11851-8. PubMed ID: 17178882
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Resection of cholangiolocellular carcinoma successfully responding to neoadjuvant hepatic arterial infusion chemotherapy - report of a case].
    Nakayama Y, Nakamura N, Ito T, Matsubayashi J, Yogo A, Kitou Y, Hanamoto K, Ura K, Taira K, Oe H, Yoshikawa A, Mitsuyoshi A, Ishigami S, Shirase T, Doi R.
    Gan To Kagaku Ryoho; 2012 Jul 15; 39(7):1155-7. PubMed ID: 22790060
    [Abstract] [Full Text] [Related]

  • 16. Sorafenib in combination with ionizing radiation has a greater anti-tumour activity in a breast cancer model.
    Heravi M, Tomic N, Liang L, Devic S, Holmes J, Deblois F, Radzioch D, Muanza T.
    Anticancer Drugs; 2012 Jun 15; 23(5):525-33. PubMed ID: 22357220
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [A case of unresectable cholangiocellular carcinoma treated with surgery followed by combination chemotherapy].
    Hayashi N, Hasuike Y, Fukuchi N, Kida H, Tujie M, Yoshida T, Ebisui C, Sakita I, Koshino T, Izumiyama K, Koro T, Fujimoto T.
    Gan To Kagaku Ryoho; 2005 Oct 15; 32(11):1852-4. PubMed ID: 16315961
    [Abstract] [Full Text] [Related]

  • 19. Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature.
    Adnane L, Trail PA, Taylor I, Wilhelm SM.
    Methods Enzymol; 2006 Oct 15; 407():597-612. PubMed ID: 16757355
    [Abstract] [Full Text] [Related]

  • 20. Hepatic intra-arterial cetuximab in combination with 5-fluorouracil and cisplatin as salvage treatment for sorafenib-refractory hepatocellular carcinoma.
    Poggi G, Montagna B, Melchiorre F, Quaretti P, Delmonte A, Riccardi A, Tagliaferri B, Sottotetti F, Di Cesare P, Stella MG, Villani L, Zorzetto M, Greco G, Cornalba G, Bernardo G.
    Anticancer Res; 2011 Nov 15; 31(11):3927-33. PubMed ID: 22110221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.